EP1365801A4 - Methodes et materiels se rapportant a des polypeptides et a des polynucleotides apparentes a la fibuline - Google Patents

Methodes et materiels se rapportant a des polypeptides et a des polynucleotides apparentes a la fibuline

Info

Publication number
EP1365801A4
EP1365801A4 EP02725104A EP02725104A EP1365801A4 EP 1365801 A4 EP1365801 A4 EP 1365801A4 EP 02725104 A EP02725104 A EP 02725104A EP 02725104 A EP02725104 A EP 02725104A EP 1365801 A4 EP1365801 A4 EP 1365801A4
Authority
EP
European Patent Office
Prior art keywords
fibulin
polynucleotides
polypeptides
methods
materials relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02725104A
Other languages
German (de)
English (en)
Other versions
EP1365801A1 (fr
Inventor
Shubhada D Godbole
Bryan J Boyle
Matthew C Arterburn
Chenghua Liu
Y Tom Tang
Radoje T Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1365801A1 publication Critical patent/EP1365801A1/fr
Publication of EP1365801A4 publication Critical patent/EP1365801A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11—Compounds covalently bound to a solid support
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
EP02725104A 2001-03-08 2002-03-08 Methodes et materiels se rapportant a des polypeptides et a des polynucleotides apparentes a la fibuline Withdrawn EP1365801A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80270401A 2001-03-08 2001-03-08
US802704 2001-03-08
PCT/US2002/007282 WO2002072138A1 (fr) 2001-03-08 2002-03-08 Methodes et materiels se rapportant a des polypeptides et a des polynucleotides apparentes a la fibuline

Publications (2)

Publication Number Publication Date
EP1365801A1 EP1365801A1 (fr) 2003-12-03
EP1365801A4 true EP1365801A4 (fr) 2004-10-13

Family

ID=25184475

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02725104A Withdrawn EP1365801A4 (fr) 2001-03-08 2002-03-08 Methodes et materiels se rapportant a des polypeptides et a des polynucleotides apparentes a la fibuline

Country Status (3)

Country Link
EP (1) EP1365801A4 (fr)
CA (1) CA2441006A1 (fr)
WO (1) WO2002072138A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1395669B1 (fr) 2001-01-26 2009-07-22 Selexis S.A. Regions se liant a la matrice nucleaire (mar) et procedes d'utilisation de celles-ci
PL2292754T3 (pl) 2003-10-24 2013-06-28 Selexis Sa Wysokowydajny transfer genu i ekspresja w komórkach ssaczych przez procedurę wielokrotnej transfekcji sekwencji regionu przylegania do macierzy
CA2616258C (fr) 2005-07-22 2014-01-21 Erasmus University Medical Center Rotterdam Modele animal non humain pour maladie cardio-vasculaire caracterisee par un gene de fibuline-4 fragmente
WO2015138411A1 (fr) 2014-03-10 2015-09-17 The Brigham And Women's Hospital, Inc. Anticorps anti-fibuline et leurs utilisations

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058473A2 (fr) * 1999-03-31 2000-10-05 Curagen Corporation Acides nucleiques comprenant des phases de lecture ouverte codant des polypeptides; «orfx»
WO2001034626A1 (fr) * 1999-11-05 2001-05-17 Human Genome Sciences, Inc. 28 proteines secretees humaines
WO2001077137A1 (fr) * 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Proteines de fusion d'albumine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204259A (en) * 1988-05-06 1993-04-20 Pharmacia Genetic Engineering, Inc. Methods and systems for producing HIV antigens
JPH05503288A (ja) * 1989-08-18 1993-06-03 ラ　ホヤ　キャンサー　リサーチ　ファウンデーション フィビュリン
WO1997038014A1 (fr) * 1996-04-04 1997-10-16 Amgen Inc. Compositions pharmaceutiques renfermant la fibuline et procedes connexes
EP1012335A4 (fr) * 1997-08-15 2004-06-09 Hyseq Inc Procedes et compositions de detection ou de quantification d'especes d'acides nucleiques
US6593104B1 (en) * 1999-02-12 2003-07-15 University Of Iowa Research Foundation Macular degeneration diagnostics and therapeutics

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058473A2 (fr) * 1999-03-31 2000-10-05 Curagen Corporation Acides nucleiques comprenant des phases de lecture ouverte codant des polypeptides; «orfx»
WO2001034626A1 (fr) * 1999-11-05 2001-05-17 Human Genome Sciences, Inc. 28 proteines secretees humaines
WO2001077137A1 (fr) * 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Proteines de fusion d'albumine

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 17 July 2001 (2001-07-17), XP002291219, retrieved from EBI Database accession no. AAE01436 *
DATABASE EMBL 27 August 2002 (2002-08-27), XP002291218, retrieved from EBI Database accession no. ABG63881 *
DATABASE EMBL 8 February 2001 (2001-02-08), XP002291217, retrieved from EBI Database accession no. AAB43080 *
See also references of WO02072138A1 *

Also Published As

Publication number Publication date
CA2441006A1 (fr) 2002-09-19
EP1365801A1 (fr) 2003-12-03
WO2002072138A1 (fr) 2002-09-19

Similar Documents

Publication Publication Date Title
EP1601758A4 (fr) Polynucleotides et polypeptides dans des plantes
AU2002341541A1 (en) Abiotic stress responsive polynucleotides and polypeptides
EP1448597A4 (fr) Polypeptides de vegetaux et polynucleotides codant pour ceux-ci
AUPQ976800A0 (en) Novel polypeptides and polynucleotides and uses therefor
IL153568A (en) Novel polypeptides and polynucleotides
EP1252333A4 (fr) Procedes et substances relatifs a des polypeptides de type cd84 et a des polynucleotides
EP1254266A4 (fr) Methodes et materiaux en rapport avec des polypeptides et de polynucleotides de type alpha-2-macroglobuline
EP1409661A4 (fr) Polypeptides d'hdac9, polynucleotides et leurs utilisations
IL156964A0 (en) Diamondoid-containing materials in microelectronics
AU2002330672A1 (en) Gmg-1 polynucleotides and polypeptides and uses thereof
GB0125131D0 (en) Improvements in and relating to conatiners
EP1365801A4 (fr) Methodes et materiels se rapportant a des polypeptides et a des polynucleotides apparentes a la fibuline
AU2002360460A8 (en) Methods and materials relating to novel polypeptides and polynucleotides
AU3486501A (en) Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
AU2002351469A8 (en) Acrp30-like polynucleotides, polypeptides, and antibodies
AU2002359351A8 (en) Methods and materials relating to prokineticin-like polypeptides and polynucleotides
IL161234A0 (en) Ngzipa, ngzipd, pgzipa and pgzipd polynucleotides and polypeptides and uses thereof
EP1254265A4 (fr) Methodes et materiaux concernant des polypeptides et des polynucleotides du type metallocarboxypeptidase
AU2002255689A1 (en) Methods and materials relating to fibulin-like polypeptides and polynucleotides
EP1240178A4 (fr) Procedes et substances relatifs a des polypeptides de type prothrombinase et a des polynucleotides
AU2003301689A8 (en) Methods and materials relating to neurotrimin-like polypeptides and polynucleotides
EP1261736A4 (fr) Methodes et materiaux associes a des polypeptides et des polynucleotides du type facteur-1 des preadipocytes (du type pref-1)
EP1409715A4 (fr) Procedes et materiaux concernant des polypeptides et des polynucleotides du type neurotrimin
AU2003240755A1 (en) Xcrf polynucleotides and polypeptides and uses thereof
AUPQ645700A0 (en) Novel polypeptides and polynucleotides and methods of using them

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030908

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040826

17Q First examination report despatched

Effective date: 20061219

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070503